Sri Usha Jeevani Obulareddy
Researcher
Also affiliated: University of Arkansas Medical Center (2023); MVJ Medical College and Research Hospital (2023); Mayo Clinic Health System (2023); Aurora Medical Center (2023); Winthrop Rockefeller Foundation (2024–2025); University of Minnesota Medical Center (2023); Virginia Mason Memorial (2024)
Unknown Researcher
Research Areas
Biography and Research Information
OverviewAI-generated summary
Sri Usha Jeevani Obulareddy's research focuses on public health and disease burdens, particularly examining the relationships between environmental factors, lifestyle choices, and health outcomes. Obulareddy has investigated the statewide burden of cancer attributable to alcohol use in the United States over the past three decades, including projections of future deaths. Additionally, Obulareddy's work includes an umbrella meta-analysis on the risk of lung cancer and associated mortality from PM 2.5 exposure. Other research interests include the role of glucagon-like peptide-1 agonists in cardiovascular diseases, a topic explored through bibliometric analysis, and the association between inflammatory bowel disease and cancer risk.
Metrics
- h-index: 2
- Publications: 8
- Citations: 14
Selected Publications
-
An overview of adaptive study design (2025)
-
Inflammatory bowel disease and risk of cancer: A nationwide study. (2025)
-
Glucagon-like peptide-1 agonists in cardiovascular diseases: a bibliometric analysis from inception to 2023 (2024)
-
Statewide burden of cancer attributable to alcohol use in the United States in the last three decades, projections of deaths to 2040: A benchmarking study. (2024)
Collaboration Network
Top Collaborators
- Statewide burden of cancer attributable to alcohol use in the United States in the last three decades, projections of deaths to 2040: A benchmarking study.
- Statewide burden of cancer attributable to alcohol use in the United States in the last three decades, projections of deaths to 2040: A benchmarking study.
- Statewide burden of cancer attributable to alcohol use in the United States in the last three decades, projections of deaths to 2040: A benchmarking study.
- Statewide burden of cancer attributable to alcohol use in the United States in the last three decades, projections of deaths to 2040: A benchmarking study.
- Statewide burden of cancer attributable to alcohol use in the United States in the last three decades, projections of deaths to 2040: A benchmarking study.
- Statewide burden of cancer attributable to alcohol use in the United States in the last three decades, projections of deaths to 2040: A benchmarking study.
- Statewide burden of cancer attributable to alcohol use in the United States in the last three decades, projections of deaths to 2040: A benchmarking study.
- Statewide burden of cancer attributable to alcohol use in the United States in the last three decades, projections of deaths to 2040: A benchmarking study.
- Statewide burden of cancer attributable to alcohol use in the United States in the last three decades, projections of deaths to 2040: A benchmarking study.
- Statewide burden of cancer attributable to alcohol use in the United States in the last three decades, projections of deaths to 2040: A benchmarking study.
- Statewide burden of cancer attributable to alcohol use in the United States in the last three decades, projections of deaths to 2040: A benchmarking study.
- Glucagon-like peptide-1 agonists in cardiovascular diseases: a bibliometric analysis from inception to 2023
- Glucagon-like peptide-1 agonists in cardiovascular diseases: a bibliometric analysis from inception to 2023
- Glucagon-like peptide-1 agonists in cardiovascular diseases: a bibliometric analysis from inception to 2023
- Glucagon-like peptide-1 agonists in cardiovascular diseases: a bibliometric analysis from inception to 2023
Similar Researchers
Based on overlapping research topics